Cargando…

Tumor-suppressive microRNA-29a inhibits cancer cell migration and invasion via targeting HSP47 in cervical squamous cell carcinoma

Our recent studies of microRNA (miRNA) expression signatures indicated that microRNA-29a (miR-29a) was significantly downregulated in several types of human cancers, suggesting that miR-29a may be a putative tumor-suppressive miRNA in human cancers. The aim of this study was to investigate the funct...

Descripción completa

Detalles Bibliográficos
Autores principales:	YAMAMOTO, NORIKO, KINOSHITA, TAKASHI, NOHATA, NIJIRO, YOSHINO, HIROFUMI, ITESAKO, TOSHIHIKO, FUJIMURA, LISA, MITSUHASHI, AKIRA, USUI, HIROKAZU, ENOKIDA, HIDEKI, NAKAGAWA, MASAYUKI, SHOZU, MAKIO, SEKI, NAOHIKO
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2013
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3834344/ https://www.ncbi.nlm.nih.gov/pubmed/24141696 http://dx.doi.org/10.3892/ijo.2013.2145

Ejemplares similares

Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion by targeting focal adhesion pathways in cervical squamous cell carcinoma
por: YAMAMOTO, NORIKO, et al.
Publicado: (2013)

The MicroRNA Expression Signature of Bladder Cancer by Deep Sequencing: The Functional Significance of the miR-195/497 Cluster
por: Itesako, Toshihiko, et al.
Publicado: (2014)

miR-1 as a tumor suppressive microRNA targeting TAGLN2 in head and neck squamous cell carcinoma
por: Nohata, Nijiro, et al.
Publicado: (2011)

Tumor suppressive microRNA-138 contributes to cell migration and invasion through its targeting of vimentin in renal cell carcinoma
por: YAMASAKI, TAKESHI, et al.
Publicado: (2012)

Tumor suppressive microRNA-1285 regulates novel molecular targets: Aberrant expression and functional significance in renal cell carcinoma
por: Hidaka, Hideo, et al.
Publicado: (2012)

Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion through targeting laminin-332 in head and neck squamous cell carcinoma
por: Kinoshita, Takashi, et al.
Publicado: (2012)

Tumour-suppressive microRNA-29s inhibit cancer cell migration and invasion by targeting laminin–integrin signalling in head and neck squamous cell carcinoma
por: Kinoshita, T, et al.
Publicado: (2013)

microRNA-1/133a and microRNA-206/133b clusters: Dysregulation and functional roles in human cancers
por: Nohata, Nijiro, et al.
Publicado: (2012)

Novel oncogenic function of mesoderm development candidate 1 and its regulation by MiR-574-3p in bladder cancer cell lines
por: TATARANO, SHUICHI, et al.
Publicado: (2011)

Tumour-suppressive microRNA-874 contributes to cell proliferation through targeting of histone deacetylase 1 in head and neck squamous cell carcinoma
por: Nohata, N, et al.
Publicado: (2013)

microRNA-210-3p depletion by CRISPR/Cas9 promoted tumorigenesis through revival of TWIST1 in renal cell carcinoma
por: Yoshino, Hirofumi, et al.
Publicado: (2017)

Characterization of PHGDH expression in bladder cancer: potential targeting therapy with gemcitabine/cisplatin and the contribution of promoter DNA hypomethylation
por: Yoshino, Hirofumi, et al.
Publicado: (2020)

Regulation of ITGA3 by the dual-stranded microRNA-199 family as a potential prognostic marker in bladder cancer
por: Sakaguchi, Takashi, et al.
Publicado: (2018)

Regulation of ITGA3 by the dual-stranded microRNA-199 family as a potential prognostic marker in bladder cancer
por: Sakaguchi, Takashi, et al.
Publicado: (2017)

Dual tumor‐suppressors miR‐139‐5p and miR‐139‐3p targeting matrix metalloprotease 11 in bladder cancer
por: Yonemori, Masaya, et al.
Publicado: (2016)

Dual regulation of receptor tyrosine kinase genes EGFR and c-Met by the tumor-suppressive microRNA-23b/27b cluster in bladder cancer
por: CHIYOMARU, TAKESHI, et al.
Publicado: (2014)

The microRNA signature of patients with sunitinib failure: regulation of UHRF1 pathways by microRNA-101 in renal cell carcinoma
por: Goto, Yusuke, et al.
Publicado: (2016)

MiR-29/Hsp47 in ECM network
por: Xu, Ren
Publicado: (2015)

Long-term outcomes of progestin plus metformin as a fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer patients
por: Mitsuhashi, Akira, et al.
Publicado: (2019)

Parental contribution to trisomy in heterozygous androgenetic complete moles
por: Usui, Hirokazu, et al.
Publicado: (2020)

Regulation of UHRF1 by dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p): inhibition of bladder cancer cell aggressiveness
por: Matsushita, Ryosuke, et al.
Publicado: (2016)

Impact of miR-1/miR-133 Clustered miRNAs: PFN2 Facilitates Malignant Phenotypes in Head and Neck Squamous Cell Carcinoma
por: Asai, Shunichi, et al.
Publicado: (2022)

The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer
por: Yoshino, H, et al.
Publicado: (2011)

Genistein Inhibits Prostate Cancer Cell Growth by Targeting miR-34a and Oncogenic HOTAIR
por: Chiyomaru, Takeshi, et al.
Publicado: (2013)

Antitumor effects of metformin via indirect inhibition of protein phosphatase 2A in patients with endometrial cancer
por: Hanawa, Shinsuke, et al.
Publicado: (2018)

The role of microRNAs in bladder cancer
por: Enokida, Hideki, et al.
Publicado: (2016)

Tumour suppressive microRNA-874 regulates novel cancer networks in maxillary sinus squamous cell carcinoma
por: Nohata, N, et al.
Publicado: (2011)

Dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p) coordinately targeted MTDH in lung squamous cell carcinoma
por: Mataki, Hiroko, et al.
Publicado: (2016)

Genome-wide single nucleotide polymorphism array analysis unveils the origin of heterozygous androgenetic complete moles
por: Usui, Hirokazu, et al.
Publicado: (2019)

Treatment results of the second-line chemotherapy regimen for patients with low-risk gestational trophoblastic neoplasia treated with 5-day methotrexate and 5-day etoposide
por: Kanno, Toshiyuki, et al.
Publicado: (2018)

Development of localized cul-de-sac endometrioid carcinoma associated with deep infiltrating endometriosis during remission of early endometrial cancer
por: Seki, Kumiko, et al.
Publicado: (2019)

Tumour suppressors miR-1 and miR-133a target the oncogenic function of purine nucleoside phosphorylase (PNP) in prostate cancer
por: Kojima, S, et al.
Publicado: (2012)

Tumor-suppressive microRNA-218 inhibits cancer cell migration and invasion via targeting of LASP1 in prostate cancer
por: Nishikawa, Rika, et al.
Publicado: (2014)

Deep sequencing-based microRNA expression signatures in head and neck squamous cell carcinoma: dual strands of pre-miR-150 as antitumor miRNAs
por: Koshizuka, Keiichi, et al.
Publicado: (2017)

FAM64A: A Novel Oncogenic Target of Lung Adenocarcinoma Regulated by Both Strands of miR-99a (miR-99a-5p and miR-99a-3p)
por: Mizuno, Keiko, et al.
Publicado: (2020)

Metformin attenuates the production and proliferative effects of prolactin induced by medroxyprogesterone acetate during fertility-sparing treatment for endometrial cancer
por: Gu, Wenjing, et al.
Publicado: (2022)

HSP47: A Therapeutic Target in Pulmonary Fibrosis
por: Sakamoto, Noriho, et al.
Publicado: (2023)

Tumor-suppressive microRNA-29 family inhibits cancer cell migration and invasion directly targeting LOXL2 in lung squamous cell carcinoma
por: MIZUNO, KEIKO, et al.
Publicado: (2015)

The microRNA-23b/27b/24-1 cluster is a disease progression marker and tumor suppressor in prostate cancer
por: Goto, Yusuke, et al.
Publicado: (2014)

Molecular Signature of Small Cell Lung Cancer after Treatment Failure: The MCM Complex as Therapeutic Target
por: Misono, Shunsuke, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8ol6g3m5t4glvgb52vuf8h1qu1